Category: Vaccines
South America Vaccines
-
Fish Vaccine Market, By Vaccine Type (Killed Vaccine, Inactivated Vaccine, Attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, Recombinant Vector Vaccines), By Indication (Furunculosis, Vibriosis, Yersiniosis, Enteric septicaemia, Others), By Route of Administration (Injection, Immersion, Spray, Oral), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... thus, avoiding heavy economic losses to fish farmers and traders. Vaccines aid immunization of fish species that are raised through aquaculture practices for both food and ornamental purposes. Growing consumption of seafood along with rising ... Read More
-
2025 Latin America Animal Vaccine Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... the Chemicals industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on equipment or ... Read More
-
Influenza Vaccines Market, By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route of Administration (Injection, Nasal Spray), By Age Group (Paediatrics, Adults), By Technology (Egg-Based Flu Vaccines, Cell Culture-Based Flu Vaccines, Recombinant Flu Vaccines), By Distribution Channel (Public, Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... element of preventive healthcare for decades. The influenza viruses have the ability to mutate and evolve regularly, necessitating the development of updated vaccines each year. The vaccines work to boost the body's immune response to ... Read More
-
Foot and Mouth Disease Vaccine Market, By Vaccine Type (Conventional Vaccine, Aluminum Hydroxide based vaccine, Oil based vaccines, Emergency Vaccines), By Animal Type (Cattle, Sheep and Goat, Swine, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... yield and growth in infected animals and indirect economic losses from control, treatment and trade restrictions. FMD is a endemic in parts of Asia, Africa, and South America where emergency vaccination is practiced to control ... Read More
-
Recombinant Dna Technology Market, By Product Type (Recombinant Protein Drugs, Vaccines , Genetically Modified Crops, Cell and Gene Therapy, and Gene Editing), By Application (Therapeutics, Agriculture, Research, and Others), By End User (Biotechnology and Pharmaceutical Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... joining together of DNA molecules from two different sources into one molecule that can replicate and direct the assembly of its own components or related proteins. This process involves physically combining and interweaving two different ... Read More
-
Veterinary Vaccines Market, By Animal Type (Companion, Livestock), By Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, Subunit and DNA Vaccines, and Recombinant Vaccines), By Route of Administration (Subcutaneous Injection, Intramuscular Injection, Intranasal Administration, and Others), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... to animals in order to stimulate the immune system and provide active immunity against a disease. Vaccination protects individual animals from infectious diseases and generates herd immunity which indirectly protects the whole community. The global ... Read More
-
Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation (Preclinical, Clinical and Commercial), Type of Vector (AAV Vectors, Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors and Other Vectors), Application Area (Gene Therapies, Cell Therapies and Vaccines), Therapeutic Area (Oncological Disorders, Rare Diseases, Neurological Disorders, Sensory Disorders, Metabolic Disorders, Musculoskeletal Disorders, Blood Disorders, Immunological Disorders and Other Disorders), Type of Manufacturer (In-house and Contract Manufacturing Organizations) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... (Gene Therapies, Cell Therapies and Vaccines), Therapeutic Area (Oncological Disorders, Rare Diseases, Neurological Disorders, Sensory Disorders, Metabolic Disorders, Musculoskeletal Disorders, Blood Disorders, Immunological Disorders and Other Disorders), Type of Manufacturer (In-house and Contract Manufacturing Organizations) ... Read More
-
mRNA Vaccine and Therapeutics Market by Application Area (Covid-19 and Other Indications), Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... the World): Industry Trends and Global Forecasts, Till 2035 mRNA Vaccine And Therapeutics Market: Overview As per Roots Analysis, the global mRNA vaccine and therapeutics market is estimated to be worth USD 1.99 billion by ... Read More
-
Biologics Contract Manufacturing Market by Type of Service(s) Offered (API, FDF), Type of Biologic Manufactured (Antibodies, Cell Therapies, Vaccines and Other Biologics), Type of Expression System Used (Mammalian, Microbial and Others), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, Till 2035
... / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, Till 2035 BIOLOGICS CONTRACT MANUFACTURING ... Read More
-
2024 Latin America Pediatric Vaccines Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Latin America Population Health Management Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Latin America Live Attenuated Vaccines Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
Vaccines Market, By Type (Monovalent Vaccines , Multitvalent Vaccines), By Technology (Conjugate Vaccines, Recombinant Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Other Vaccine Technologies), By Disease Indication (Pneumococcal Disease, Influenza, Combination Vaccines, HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, Other Disease Indications), By Route of Administration (Intramuscular, Subcutaneous, Oral, Intranasal), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, Other Disease Indications), By Route of Administration (Intramuscular, Subcutaneous, Oral, Intranasal), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & ... Read More
-
Global Dengue Vaccine Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2030
... Segment Forecasts, 2023 – 2030 The Global Dengue Vaccine Market was valued around US $390.55 million in 2022 and is expected to reach US $1292.20 million by 2030 with a CAGR of 16.13% during the ... Read More
-
Downstream Processing Market, By Technique (Purification Techniques, Solid-Liquid Separation, and Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Evaporators, Centrifuges, and Other Products), By Application (Antibodies Production, Vaccines Production, Insulin Production, and Other Applications), By End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Downstream processing refers to the purification and recovery steps in bioprocessing undertaken ... Read More
-
Single-Use Bioreactor Market, By Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, and Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The single-use ... Read More
-
Bovine Mastitis Market, by Type (Clinical Mastitis and Sub-clinical Mastitis), by Product (Antibiotics, Vaccines, Pain Killers, and Others), by Route of Administration (Intra-mammary and Systemic), by Therapy (Lactating Period, Dry Period (Antibiotics, and Teat Sealants)), by End User (Veterinary Centers, Hospital, Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... by End User (Veterinary Centers, Hospital, Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 Bovine mastitis ... Read More
-
IPV Vaccines Market, by Vaccine Brand (POLIOVAC (PFS/SD), SHANIPV, POLIORIX, IPOL/IMOVAX, And POLYMILEX), by Distribution Channel (Private and Public), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... Share, Outlook, and Opportunity Analysis, 2024 - 2031 Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. ... Read More
-
Nanomedicine Therapeutics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2030, Segmented By Indication (Oncology, Infectious Disease, Cardiology, Neurological Disease); By Application (Drug Delivery, Regenerative Medicine, Vaccines, Active Implants); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA))
... America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)) Global Nanomedicine Therapeutics Market Size Booming at CAGR of 9.42% to Surpass Whopping USD 369 Billion by 2030 Global Nanomedicine Therapeutics Market ... Read More
-
Plant-based Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global plant-based vaccines market, which amassed revenues of US$ 1.6 billion in 2024, is expected to achieve a valuation of US$ 2.9 billion by the close of 2031. Plant-based vaccines have emerged as a promising ... Read More
-
West Nile Virus Market, By Product Type (Antivirals, Vaccines, Antibiotics, Analgesics, and Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Pacific, Latin America, Middle East, and Africa) West Nile virus (WNV) is a mosquito-borne disease that affects humans, birds, and other animals. It was first identified in the West Nile region of Uganda in 1937 ... Read More
-
Flu Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global Flu Vaccines Market displayed robust performance in 2024, with revenues reaching approximately US$ 5.7 billion. The market is projected to achieve a valuation of around US$ 10 billion by the end of 2031. Flu ... Read More
-
Autogenous Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global autogenous vaccines market is on a growth trajectory, with worldwide revenue reaching US$ 140 million in 2024. According to a recent analysis report, the market is projected reach US$ 220 million by the end ... Read More
-
Brazil 23 Valent Pneumococcal Polysaccharide Vaccine Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... study of the Brazil market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Brazil market. Also, factors that are driving and restraining the 23 valent ... Read More
-
Viral Vector Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global viral vector vaccines market has exhibited impressive growth reaching a market size of US$ 780 million at the close of 2024, according to a recent study by Fairfield Market Research. The market is ... Read More
Research Assistance
